Abbott Laboratories ABT
NYSE ABT
$105.75 +0.23 (+0.22%)
As of: Sep 9, 2026 · 12:54 PM EDT

Abbott Laboratories (ABT) Cash & Equivalents Growth (5y) (2014 - 2026)

Analysis

Abbott Laboratories (ABT) Cash & Equivalents Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.86 Bn 178.25 Bn 7.27 Bn
2 Intuitive Surgical 124.18 Bn 118.97 Bn 1.96 Bn
3 Medtronic 118.18 Bn 109.36 Bn 6.34 Bn
4 Stryker 104.54 Bn 101.07 Bn 4.50 Bn
5 Boston Scientific 66.34 Bn 65.80 Bn 3.85 Bn
6 Edwards Lifesciences 49.64 Bn 45.39 Bn 1.35 Bn
7 Alcon 33.93 Bn 32.47 Bn 1.68 Bn
8 Dexcom 32.20 Bn 30.25 Bn 830.00 Mn
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.11 Bn 17.70 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.03%
Mar 31, 2026 -3.32%
Dec 31, 2025 4.50%
Sep 30, 2025 10.89%
Jun 30, 2025 7.85%
Mar 31, 2025 14.10%
Dec 31, 2024 14.56%
Sep 30, 2024 13.06%
Jun 30, 2024 17.37%
Mar 31, 2024 15.77%
Dec 31, 2023 12.40%
Sep 30, 2023 -1.86%
Jun 30, 2023 20.65%
Mar 31, 2023 18.89%
Dec 31, 2022 0.99%
Sep 30, 2022 -2.72%
Jun 30, 2022 -1.57%
Mar 31, 2022 -2.49%
Dec 31, 2021 -12.05%
Sep 30, 2021 30.06%